Clinical Trial Update: Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis [NA]

View source ↗

Summary

This update notes the completion of a clinical trial evaluating soluble VE-cadherin and VE-cadherin antibody in primary Raynaud's disease and systemic sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon Primary
• Systemic Sclerosis

Drugs mentioned

• Soluble VE-cadherin (soluble VE-cadherin)
• VE-cadherin antibody (VE-cadherin antibody)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Primary Raynaud Disease, Systemic Sclerosis | NA | Status: COMPLETED